findmyKOL

Charles Loprinzi, MD

Enriched profile

Regis Professor of Breast Cancer Research (Emeritus Chair, Division of Medical Oncology; Emeritus Vice-Chair, Department of Oncology) -- recently retired per 2026 award coverage · Mayo Clinic

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyMedical OncologyFocusCancer Treatment and Pharmacology+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1994–2024

Charles Loprinzi is Regis Professor of Breast Cancer Research (Emeritus Chair, Division of Medical Oncology; Emeritus Vice-Chair, Department of Oncology) -- recently retired per 2026 award coverage at Mayo Clinic. OpenAlex indexes 843 publications with 49,105 citations (h-index 108); ClinicalTrials.gov lists 37 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Charles L. Loprinzi, MD, is Regis Professor of Breast Cancer Research (Emeritus Chair, Division of Medical Oncology at Mayo Clinic, Rochester, Minnesota. The public record shows 843 publications with 49,105 citations (h-index 108), centered on Cancer Treatment and Pharmacology, Estrogen and related hormone effects, Menopause: Health Impacts and Treatments. It also documents an investigator role on 37 registered clinical trials, industry payments reported by 8 companies, 4 NIH-funded awards (1994–2024).

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Cancer Treatment and Pharmacology
  • 37 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer13 trialsPain12 trialsHot Flashes8 trialsColorectal Cancer2 trialsRectal Neoplasms2 trialsProstate Cancer2 trialsOsteoporosis2 trialsLeukemia (AML/ALL/CML/CLL)2 trialsLymphoma2 trialsMultiple Myeloma2 trialsFatigue1 trialSleep Wake Disorders1 trialMelanoma1 trialArthralgia1 trialAcute Pain1 trialOvarian / Gynecologic Cancer1 trialFallopian Tube Neoplasms1 trialBreast Carcinoma In Situ1 trialCarcinoma in Situ1 trialHypesthesia1 trial

Research focus

OpenAlex concept fingerprint
Cancer Treatment and PharmacologyEstrogen and related hormone effectsMenopause: Health Impacts and TreatmentsChemotherapy-related skin toxicityColorectal Cancer Treatments and Studies

Drugs & molecules

across trials, industry payments and publications
Envarsusgeneric · TacrolimusClinical trials—Industry payments3Publications—Enhertugeneric · TrastuzumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Alliance for Clinical Trials in OncologyClinical trials18Industry payments—Mayo ClinicClinical trials15Industry payments—Academic and Community Cancer Research UnitedClinical trials4Industry payments—Veloxis Pharmaceuticals, Inc.Clinical trials—Industry payments3AVEO Pharmaceuticals, Inc.Clinical trials—Industry payments2Nevro Corp.Clinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1AstraZeneca UK LimitedClinical trials—Industry payments1Genentech, Inc.Clinical trials—Industry payments1Gilead Sciences, Inc.Clinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
843publications

Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.

49,105citations

Total citations across indexed works.

108h-index

Hirsch index (OpenAlex). i10-index 429.

Clinical & industry

trials, payments and federal funding
37clinical trials

Investigator role on registered studies.

View trials ↓
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 1994–2024

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 37 registered studies on ClinicalTrials.gov. The most recent:

All 37 trial records: search, sort and filter.Explore →

Industry payments

Updated 16 Oct 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 10 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Aromatase Inhibitor100%
    Anastrozole100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

4 NIH research awards on record, funded 1994–2024 per NIH RePORTER. The latest:

All 61 award records: search, sort and filter.Explore →

Congress activity

Updated 16 Oct 2026

131 congress contributions (1999–2025) across AACR, ASCO, ASH, ASTRO, SABCS per OpenAlex. The most recent:

All 131 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 19 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Definition and classification of cancer cachexia: an international consensus
    Article5,701 citations2011
    doi.org ↗
  2. 02
    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
    Article1,226 citations2014
    doi.org ↗
  3. 03
    A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
    Article1,151 citations2003
    doi.org ↗
  4. 04
    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
    Article1,079 citations2020
    doi.org ↗
  5. 05
    Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?
    Article1,017 citations2004
    doi.org ↗
All 843 cited works: search, sort and filter.Explore →

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jeff A. Sloan175Debra L. Barton119Paul J. Novotny106Kathryn J. Ruddy96Shaker R. Dakhil53Aminah Jatoi47Rui Qin41Maryam B. Lustberg40Jennifer Le‐Rademacher39Elizabeth Cathcart-Rake36Kendrith M. Rowland35Fergus J. Couch34Deirdre R. Pachman32Janet E. Olson29Patrick J. Flynn28Philip J. Stella27Thomas J. Smith27Andreas S. Beutler26Drew K. Seisler25Vered Stearns24Axel Grothey24Paul Schaefer22Loren K. Tschetter22Al B. Benson21Heshan Liu21Lisa A. Kottschade21Judith R. OʼFallon21Jacqueline M. Lafky20Edith A. Perez20James A. Mailliard20Steven R. Alberts19N. Lynn Henry19Michael Fisch19James E. Krook19Jeffrey L. Berenberg18Sherry L. Wolf18Victor T. Chang18Nicole L. Larson18Robert D. McBane18Timothy J. Moynihan18

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/charles-loprinzi-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/charles-loprinzi-67924120

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Charles-Loprinzi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    mayoclinic.elsevierpure.com/en/persons/charles-lawrence-loprinzi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗
  • Other

    oncologytube.com/charles-loprinzi-md-mayoclinic-miamibreast22-breast22-cipn-chemotherapy-induced-neuropathy

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncologytube.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/managing-cancer-cachexia-with-charles-loprinzi-md/id1334855695

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/prevention-and-management-of-chemotherapy/id1348000511

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/prevention-management-chemotherapy-induced-peripheral/id1348000511

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
  • Other

    sites.libsyn.com/112891/preventing-and-managing-peripheral-neuropathy-with-charles-loprinzi-md-fasco

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →sites.libsyn.com ↗
  • Other

    cancer.net/blog/podcasts/managing-cancer-cachexia-with-charles-loprinzi-md-fasco-and-hester-hill-schnipper-licsw

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancer.net ↗
  • Other

    giantsofcancercare.com/recipients/2015/30

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
  • Other

    onclive.com/authors/charles-loprinzi-md-mayo-clinic-rochester

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn profile (auth-walled; corroborated via SERP snippet showing "Charles Loprinzi - Mayo Clinic")

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • LinkedIn

    LinkedIn profile "Charles Loprinzi - Mayo Clinic" (auth-walled; corroborated via SERP snippet only)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • Doximity

    Doximity physician profile, Dr. Charles Loprinzi, MD - Rochester, MN (Oncology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Associate editor (2004, 2008) and chief editor (2013, 2015)

    MASCC/ASCO Self Evaluation Program

    2015
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prevention.cancer.gov ↗
  • Associate editor (2004, 2008) and chief editor (2013, 2015)

    ASCO Self-Evaluation Program

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prevention.cancer.gov ↗
  • Chief editor (2013, 2015)

    ASCO Self-Evaluation Program

    2015
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prevention.cancer.gov ↗
  • Founding editor

    "Art of Oncology" section, Journal of Clinical Oncology

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
  • Founding editor

    Art of Oncology section, Journal of Clinical Oncology

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.elsevierpure.com ↗
  • Founding editor

    "Art of Oncology" section, Journal of Clinical Oncology (2000-2010); edited two resulting anthologies

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
  • Founding editor

    "Art of Oncology" section, Journal of Clinical Oncology

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗
  • Founding editor

    "Art of Oncology" section, Journal of Clinical Oncology

    2010
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prevention.cancer.gov ↗
  • Associate editor (2004, 2008)

    Multinational Association for Supportive Care in Cancer

    2008
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prevention.cancer.gov ↗
  • Chief editor (2013, 2015) and associate editor (2004, 2008)

    ASCO Self-Evaluation Program (SEP)

    2008
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prevention.cancer.gov ↗
  • Chair

    Alliance for Clinical Trials in Oncology Symptom Intervention Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prevention.cancer.gov ↗
  • Director

    North Central Cancer Treatment Group (NCCTG) Cancer Control Program

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ipcrc.net ↗
  • Co-Director

    Mayo Cancer Center Prevention and Control Program

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ipcrc.net ↗
  • Emeritus Chair

    Division of Medical Oncology, Mayo Clinic

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
  • Emeritus Vice-Chair

    Department of Oncology, Mayo Clinic

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
  • Fellow

    American Society of Clinical Oncology (FASCO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
  • Longtime principal investigator

    North Central Cancer Treatment Group (NCCTG) Community Clinical Oncology Program research base / symptom control program (later Alliance for Clinical Trials in Oncology)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
  • Leadership roles with the Multinational Association for Supportive Care in Cancer (MASCC)
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prevention.cancer.gov ↗
  • Emeritus chair

    Division of Medical Oncology, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →walther.org ↗
  • Emeritus vice-chair

    Department of Oncology, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →walther.org ↗
  • Fellow

    American Society of Clinical Oncology (FASCO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
  • Principal investigator

    North Central Cancer Treatment Group / Community Clinical Oncology Program research base (over a decade)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →giantsofcancercare.com ↗
  • Principal investigator

    North Central Cancer Treatment Group / NCI Community Clinical Oncology Program (CCOP) research base (over a decade)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayoclinic.elsevierpure.com ↗
  • Emeritus chair

    Division of Medical Oncology, and emeritus vice-chair, Department of Oncology, Mayo Clinic

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.